Literature DB >> 30232769

Autosomal-recessive iron deficiency anemia, dystonia and hypermanganesemia caused by new variant mutation of the manganese transporter gene SLC39A14.

Adel Zeglam1, Abdusalam Abugrara2, Mariam Kabuka3.   

Abstract

This inborn error of manganese metabolism has only recently been identified. A total of 28 affected individuals from ten families are known worldwide. Mutations in SLC39A14, encoding a Mn uptake transporter, have recently been recognized to cause excessive Mn concentrations in the blood which is believed to be neurotoxic and lead to a parkinsonian-like movement disorder caused by accumulation of Mn in the basal ganglia. We are reporting a new variant of SLC39A14 gene mutation (OMIM 608736 8p21.3) that has never been described in the literature so far. The index case is a 3-year-old female who was born at 30 weeks' gestation by emergency lower segment caesarean section, the second of twins, weighing 1.4 kg. Parents have a consanguineous marriage (first cousins) and have four healthy male children. She presented at 30 months of age with history of unsteady gait of 4 months duration and is progressively worsening. She became stiff and has lost all of her locomotor skills. Apart from low serum iron and iron deficiency anemia, her initial work up was unremarkable. T1-weighted MRI brain showed bilateral hyperintense signal in basal ganglia, mid-brain and pontine tegmentum giving rise to the characteristic eye-of-the-tiger sign. Genetic DNA evaluation (Whole Exome Sequencing WES) identified the homozygous missense variant c.1136.T in exon 7 of SLC39A14 gene which is associated with hypermanganesemia. Whole blood Mn was markedly raised at 150 nmol/L (8 mg/L) (normal 10 nmol/L, 0.7 mg/Bioscientia). This young girl has just started treatment with intravenous disodium calcium edetate and oral iron.

Entities:  

Keywords:  Dystonia; Eye of tiger; Hypermanganesemia; Libya; SLC39A14; Tripoli

Mesh:

Substances:

Year:  2018        PMID: 30232769     DOI: 10.1007/s13760-018-1024-7

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  13 in total

1.  Benign SLC39A14 Course of Dystonia-Parkinsonism Secondary to Inherited Manganese Accumulation.

Authors:  Montaser Namnah; Max Bauer; Hagar Mor-Shaked; Susan B Bressman; Deborah Raymond; Laurie J Ozelius; David Arkadir
Journal:  Mov Disord Clin Pract       Date:  2020-05-07

2.  Intestine-specific deletion of metal transporter Zip14 (Slc39a14) causes brain manganese overload and locomotor defects of manganism.

Authors:  Tolunay B Aydemir; Trista L Thorn; Courtney H Ruggiero; Marjory Pompilus; Marcelo Febo; Robert J Cousins
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-31       Impact factor: 4.052

3.  Clinical Profile and Treatment Outcomes of Hypermanganesemia with Dystonia 1 and 2 among 27 Indian Children.

Authors:  Divyani Garg; Sangeetha Yoganathan; Uzma Shamim; Kshitij Mankad; Parveen Gulati; Vincenzo Bonifati; Abhijeet Botre; Umesh Kalane; Arushi Gahlot Saini; Naveen Sankhyan; Kavita Srivastava; Vykuntaraju K Gowda; Monica Juneja; Mahesh Kamate; Hansashree Padmanabha; Debasis Panigrahi; Shaila Pachapure; Vrajesh Udani; Atin Kumar; Sanjay Pandey; Maya Thomas; Sumita Danda; Shaikh Atif Iqbalahmed; Annadurai Subramanian; Harish Pemde; Varinder Singh; Mohammed Faruq; Suvasini Sharma
Journal:  Mov Disord Clin Pract       Date:  2022-08-12

4.  The Combined Inactivation of Intestinal and Hepatic ZIP14 Exacerbates Manganese Overload in Mice.

Authors:  Caitlin K Fung; Ningning Zhao
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

5.  Loss of slc39a14 causes simultaneous manganese hypersensitivity and deficiency in zebrafish.

Authors:  Karin Tuschl; Richard J White; Chintan Trivedi; Leonardo E Valdivia; Stephanie Niklaus; Isaac H Bianco; Chris Dadswell; Ramón González-Méndez; Ian M Sealy; Stephan C F Neuhauss; Corinne Houart; Jason Rihel; Stephen W Wilson; Elisabeth M Busch-Nentwich
Journal:  Dis Model Mech       Date:  2022-06-15       Impact factor: 5.732

Review 6.  Manganese-induced neurodegenerative diseases and possible therapeutic approaches.

Authors:  Airton C Martins; Priscila Gubert; Gustavo R Villas Boas; Marina Meirelles Paes; Abel Santamaría; Eunsook Lee; Alexey A Tinkov; Aaron B Bowman; Michael Aschner
Journal:  Expert Rev Neurother       Date:  2020-09-02       Impact factor: 4.618

Review 7.  Molecular Targets of Manganese-Induced Neurotoxicity: A Five-Year Update.

Authors:  Alexey A Tinkov; Monica M B Paoliello; Aksana N Mazilina; Anatoly V Skalny; Airton C Martins; Olga N Voskresenskaya; Jan Aaseth; Abel Santamaria; Svetlana V Notova; Aristides Tsatsakis; Eunsook Lee; Aaron B Bowman; Michael Aschner
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

8.  Restriction of Manganese Intake Prevents the Onset of Brain Manganese Overload in Zip14-/- Mice.

Authors:  Yuze Wu; Guojun Wei; Ningning Zhao
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

Review 9.  The Functions of ZIP8, ZIP14, and ZnT10 in the Regulation of Systemic Manganese Homeostasis.

Authors:  James W W Winslow; Kirsten H Limesand; Ningning Zhao
Journal:  Int J Mol Sci       Date:  2020-05-07       Impact factor: 5.923

10.  Behavioral and neurochemical studies of inherited manganese-induced dystonia-parkinsonism in Slc39a14-knockout mice.

Authors:  Alexander N Rodichkin; Melissa K Edler; Jennifer L McGlothan; Tomás R Guilarte
Journal:  Neurobiol Dis       Date:  2021-08-04       Impact factor: 7.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.